4073 Results

People

  1. Hudis
    Hudis
  2. Giralt
    Giralt
  3. Gonen
    Gonen
  4. Levine
    Levine
  5. Scher
    Scher
  6. Fong
    Fong
  7. Motzer
    Motzer
  8. Ladanyi
    Ladanyi
  9. Travis
    Travis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)
  7. Department of Pathology and Laboratory Medicine (556)
  8. Center for Hematologic Malignancies (550)
  9. Hematologic Malignancies, Division of (465)
  10. Epidemiology and Biostatistics (464)
  1. "2013"
Formats
  1. Journal Article (2495)
  2. Meeting Abstract (1292)
  3. Book Section (250)
  4. Conference Paper (18)
  5. Book Whole (17)
  6. Review (1)
Groups
  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)

More Groups

People
  1. Jose Baselga (74)
  2. Clifford Hudis (69)
  3. Jedd Wolchok (65)
  4. Howard Scher (62)
  5. Mithat Gonen (62)
  6. Ross Levine (62)

More People

Years
  1. 2013 (4073)
Publications
  1. Journal of Clinical Oncology (366)
  2. Blood (190)
  3. Cancer Research (119)
  4. International Journal of Radiation Oncology, Biology, Physics (88)
  5. Modern Pathology (88)
  6. Laboratory Investigation (81)

More Publications

Publishers
  1. Elsevier Inc. (502)
  2. American Society of Clinical Oncology (386)
  3. Springer (304)
  4. Nature Publishing Group (249)
  5. Elsevier Science, Inc. (206)
  6. American Society of Hematology (192)

More Publishers

Results (4073)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Integrated genomic analysis by whole exome and transcriptome sequencing of tumor samples from EGFR-mutant non-small-cell lung cancer (NSCLC) patients (p) with acquired resistance to erlotinib
    Meeting Abstract

    Weissman, J. S.; Giannikopoulos, P.; St. John, J.; Uzilov, A. V.; Costa, C.; Karachaliou, N.; Sansano, I.; Jantus-Lewintre, E.; Stahel, R. A.; Vergnenegre, A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Effective monotherapy despite intratumor heterogeneity: Clonal convergence within the PI3K pathway and sensitivity to mTOR inhibitors in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Chen, Y.; Pham, C. G.; Brannon, A. R.; Scott, S. N.; Takeda, S.; Liu, H.; Motzer, R. J.; Berger, M. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients with advanced solid tumors: Survival and long-term safety in a phase I trial
    Meeting Abstract

    Topalian, S. L.; Sznol, M.; Brahmer, J. R.; McDermott, D. F.; Smith, D. C.; Gettinger, S. N.; Taube, J. M.; Drake, C. G.; Pardoll, D. M.; Powderly, J. D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Noninvasive measurement of prostate-specific membrane antigen (PSMA) expression with radiolabeled J591 imaging: A prognostic tool for metastatic castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Tagawa, S. T.; Akhtar, N. H.; Christos, P. J.; Osborne, J.; Vallabhajosula, S.; Freedy, S.; Goldsmith, S. J.; Nanus, D. M.; Bander, N. H.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • TBCRC 019: An open label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel (nab-PAC) with or without the anti-death receptor 5 (DR5) monoclonal antibody tigatuzumab (TIG) in patients with metastatic triple negative breast cancer (TNBC)
    Meeting Abstract

    Vakiavas, C.; Abramson, V. G.; Lin, N. U.; Liu, M. C.; Rugo, H. S.; Nanda, R.; Storniolo, A. M.; Traina, T. A.; Li, Y.; Patil, S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Hyaluronidase synthase 3 (HAS3) variant and anthracycline-related cardiomyopathy: A report from the Children's Oncology Group
    Meeting Abstract

    Sun, C. L.; Wang, X.; Liu, W.; Armenian, S.; Hankonarson, H.; Hageman, L.; Ding, Y.; Landier, W.; Keller, F. G.; Neglia, J. P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • 25-hydroxyvitamin D levels and survival in patients with advanced pancreatic cancer (APC): Findings from CALGB 80303
    Meeting Abstract

    Van Loon, K.; Owzar, K.; Jiang, C.; Kindler, H. L.; Mulcahy, M. F.; Niedzwiecki, D.; O'Reilly, E. M.; Fuchs, C. S.; Innocenti, F.; Venook, A. P.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • An exploratory study of the biologic effects of nivolumab (Anti-PD-1; BMS-936558; ONO-4538) treatment in patients (pts) with advanced (unresectable or metastatic) melanoma (MEL)
    Meeting Abstract

    Sosman, J. A.; Martin-Algarra, S.; Wolchok, J. D.; Sharfman, W. H.; Bhatia, S.; Hodi, F. S.; Hwu, W. J.; Gajewski, T.; Slingluff, C. L.; Kaufman, H.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Subgroup analysis of crizotinib versus either pemetrexed (PEM) or docetaxel (DOC) in the phase III study (PROFILE 1007) of advanced ALK-positive non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Solomon, B. J.; Gettinger, S. N.; Riely, G. J.; Gadgeel, S. M.; Nokihara, H.; Han, J. Y.; Hida, T.; Satouchi, M.; Baldini, E.; Siena, S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Tivozanib in patients treatment-naive for metastatic renal cell carcinoma: A subset analysis of the phase III TIVO-1 study
    Meeting Abstract

    Sternberg, C. N.; Eisen, T.; Tomczak, P.; Strahs, A. L.; Esteves, B.; Berkenblit, A.; Motzer, R. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save